The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated to advancing critical research in developing better early detection methods, improving life-saving treatments and finding a cure for prostate cancer.
|
LOS ANGELES, /PRNewswire/ -- The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated to advancing critical research in developing better early detection methods, improving life-saving treatments and finding a cure for prostate cancer. Sponsored by the PCF, the Young Investigator Awards program provides both financial support and a comprehensive career development program to early career scientists with unique approaches and groundbreaking ideas to drive the critical research needed to defeat prostate cancer, a disease that nearly 14 million men worldwide are currently battling. "We are honored to invest in new cutting-edge ideas for prostate cancer research. This year's recipients show great potential for unlocking new discoveries and achieving unprecedented strides toward research leading the way to help countless men affected by the disease," said Jonathan Simons, MD, PCF's President and CEO. As a nonprofit organization committed to globally accelerating the development of new breakthroughs in prostate cancer, the PCF has invested more than $53 million to support 255 young investigators since 2007. The 2018 Young Investigator Awards recipients were selected from a pool of 103 applications from 55 institutions in 11 countries. Recipients of the PCF Young Investigator Award must demonstrate significant promise for having a long-term and impactful career in the prostate cancer research field. Awardees must be within six years of completing professional scientific training programs and be under the guidance of at least one mentor. Eleven of the 2018 PCF Young Investigator Awardees are conducting research to improve prostate cancer outcomes in U.S. Veterans. Additional research focus areas include: novel precision medicine; new treatments and treatment strategies; immunotherapy; studying inherited genetic alterations for those at increased risk; and prostate cancer disparities particularly among African-American men. The 2018 Young Investigator Awards recipients are: Name Institution Donor(s)
- Saud AlDubayan, MD Harvard: Dana-Farber Paz Littman and Morris Kahn
Cancer Institute
- Mohammad Asim, PhD University of Surrey, Clovis Oncology, Inc.
United Kingdom
- Hala Borno, MD University of California, Lenny Sands
San Francisco
- Frank Cackowski, MD, University of Michigan Jay Jordan
PhD
- Megan Caram, MD University of Michigan Tony D. Minella
- Kellie Cotter, PhD University of Bern, Todd Boehly
Switzerland
- Anis Hamid, MBBS Harvard: Dana-Farber Jeremy Coller
Cancer Institute
- Jennifer Jones, MD, PhD National Cancer Institute National Cancer Institute
- Salma Kaochar, PhD Baylor College of Medicine John and Daria Barry
Foundation
- Sheng-Yu Ku, PhD Weill Cornell Medicine Michael and Lori Milken
Family Foundation
- Hui Li, PhD University of California, John and Daria Barry
San Francisco Foundation
- Brandon Mahal, MD Harvard: Dana-Farber American Society for
Cancer Institute Radiation Oncology
- Danil Makarov, MD New York University Thomas H. Lee
- Megan McNamara, MD Duke University Thomas Finke
- Kent Mouw, MD, PhD Harvard: Dana-Farber Rebecca and Nathan
Cancer Institute Milikowsky
- Vivek Narayan, MD University of James Maguire
Pennsylvania, Abramson
Cancer Center
- David Oh, MD, PhD University of California, John and Daria Barry
San Francisco Foundation
- Eileen Parkes, MD, PhD Queen's University Belfast, Foundation 14
Northern Ireland
- Raquel Perez-Lopez, MD, Vall d'Hebron Institute of Gina Rinehart
PhD Oncology, Spain
- Sethuramasundaram University of Michigan Keith Frankel, Michael
Pitchiaya, PhD DeAddio, and Thomas H. Lee
- Nicholas Reder, MD, University of Washington Seth Bernstein
MPH
- Zachery Reichert, MD, University of Michigan Igor Tulchinsky
PhD
- Veronica Rodriguez-
Bravo, PhD Thomas Jefferson Clay Hamlin in honor of H.
University, Sidney Kimmel Ward Hamlin Jr.
Cancer Center
- Joshua Russo, MD, PhD Harvard: Beth Israel Michael and Lori Milken
Deaconess Medical Center Family Foundation
- Adam Sharp, MD, PhD Institute of Cancer Larry Ruvo
Research, London, United Kingdom
- Min Yuen Teo, MD Memorial Sloan Kettering Michael and Lori Milken
Cancer Center Family Foundation in Honor of
Selma Rabin
-Vasanthi Viswanathan,
PhD Harvard: Broad Institute of Seth Bernstein
MIT & Harvard
- Scott Wilkinson, PhD National Cancer Institute National Cancer Institute
- David Wise, MD, PhD New York University John and Daria Barry
Foundation
For more information about the 2018 Young Investigator Awards recipients, visit LINK TO PAGE. About the Prostate Cancer Foundation (PCF): PCF is the world's leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $765 million and provided funding to more than 2,000 research programs at nearly 210 cancer centers and universities. The PCF global research enterprise now extends to 22 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. For more information, visit www.pcf.org. MEDIA CONTACT: Donald Wilson
View original content with multimedia:http://www.prnewswire.com/news-releases/the-prostate-cancer-foundation-announces-recipients-of-the-2018-pcf-young-investigator-awards-300703138.html SOURCE Prostate Cancer Foundation |
